Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease. (2021)
Attributed to:
CHARACTERISING KYNURENINE 3-MONOOXYGENASE (KMO) AS A THERAPEUTIC TARGET FOR HUNTINGTON'S DISEASE
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-021-84858-7
PubMed Identifier: 33750843
Publication URI: http://europepmc.org/abstract/MED/33750843
Type: Journal Article/Review
Volume: 11
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322